chrX-124365786-C-T
Position:
Variant summary
Our verdict is Pathogenic. Variant got 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong
The NM_002351.5(SH2D1A):c.163C>T(p.Arg55Ter) variant causes a stop gained change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★★). Variant results in nonsense mediated mRNA decay.
Frequency
Genomes: not found (cov: 22)
Exomes 𝑓: 0.0 ( 0 hom. 0 hem. )
Failed GnomAD Quality Control
Consequence
SH2D1A
NM_002351.5 stop_gained
NM_002351.5 stop_gained
Scores
2
1
2
Clinical Significance
Conservation
PhyloP100: 1.14
Genes affected
SH2D1A (HGNC:10820): (SH2 domain containing 1A) This gene encodes a protein that plays a major role in the bidirectional stimulation of T and B cells. This protein contains an SH2 domain and a short tail. It associates with the signaling lymphocyte-activation molecule, thereby acting as an inhibitor of this transmembrane protein by blocking the recruitment of the SH2-domain-containing signal-transduction molecule SHP-2 to its docking site. This protein can also bind to other related surface molecules that are expressed on activated T, B and NK cells, thereby modifying signal transduction pathways in these cells. Mutations in this gene cause lymphoproliferative syndrome X-linked type 1 or Duncan disease, a rare immunodeficiency characterized by extreme susceptibility to infection with Epstein-Barr virus, with symptoms including severe mononucleosis and malignant lymphoma. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2008]
STAG2 (HGNC:11355): (STAG2 cohesin complex component) The protein encoded by this gene is a subunit of the cohesin complex, which regulates the separation of sister chromatids during cell division. Targeted inactivation of this gene results in chromatid cohesion defects and aneuploidy, suggesting that genetic disruption of cohesin is a cause of aneuploidy in human cancer. Alternatively spliced transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Sep 2013]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Pathogenic. Variant got 18 ACMG points.
PVS1
Loss of function variant, product undergoes nonsense mediated mRNA decay. LoF is a known mechanism of disease.
PM2
Very rare variant in population databases, with high coverage;
PP5
Variant X-124365786-C-T is Pathogenic according to our data. Variant chrX-124365786-C-T is described in ClinVar as [Pathogenic]. Clinvar id is 10898.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chrX-124365786-C-T is described in Lovd as [Likely_pathogenic].
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SH2D1A | NM_002351.5 | c.163C>T | p.Arg55Ter | stop_gained | 2/4 | ENST00000371139.9 | NP_002342.1 | |
SH2D1A | NM_001114937.3 | c.163C>T | p.Arg55Ter | stop_gained | 2/4 | NP_001108409.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SH2D1A | ENST00000371139.9 | c.163C>T | p.Arg55Ter | stop_gained | 2/4 | 1 | NM_002351.5 | ENSP00000360181 | P3 |
Frequencies
GnomAD3 genomes Cov.: 22
GnomAD3 genomes
Cov.:
22
GnomAD4 exome Data not reliable, filtered out with message: AC0 AF: 0.00 AC: 0AN: 1063904Hom.: 0 Cov.: 24 AF XY: 0.00 AC XY: 0AN XY: 335730
GnomAD4 exome
Data not reliable, filtered out with message: AC0
AF:
AC:
0
AN:
1063904
Hom.:
Cov.:
24
AF XY:
AC XY:
0
AN XY:
335730
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome Cov.: 22
GnomAD4 genome
Cov.:
22
ClinVar
Significance: Pathogenic
Submissions summary: Pathogenic:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
X-linked lymphoproliferative disease due to SH2D1A deficiency Pathogenic:2
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Sep 15, 2022 | For these reasons, this variant has been classified as Pathogenic. Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may disrupt the consensus splice site. ClinVar contains an entry for this variant (Variation ID: 10898). This variant is also known as C462T. This premature translational stop signal has been observed in individual(s) with X-linked lymphoproliferative disease (PMID: 9771704, 11520777, 19621458, 24923536, 27209435). This variant is not present in population databases (gnomAD no frequency). This sequence change creates a premature translational stop signal (p.Arg55*) in the SH2D1A gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in SH2D1A are known to be pathogenic (PMID: 9771704, 11049992, 15711562). - |
Pathogenic, no assertion criteria provided | literature only | OMIM | Mar 05, 2000 | - - |
X-linked lymphoproliferative syndrome Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Women's Health and Genetics/Laboratory Corporation of America, LabCorp | May 19, 2017 | Variant summary: The SH2D1A c.163C>T (p.Arg55X) variant results in a premature termination codon, predicted to cause a truncated or absent SH2D1A protein due to nonsense mediated decay, which are commonly known mechanisms for disease. Functional studies showed no signaling lymphocyte activation moleculeassociated protein (SAP) expression in NK cells and no (or limited) expression in T cells in XLP patients. One truncation downstream of this position has been classified as pathogenic by our laboratory (e.g. c.191G>A, p.Trp64X). One in silico tool predicts a damaging outcome for this variant. The variant of interest was absent in a large, broad control population, ExAC in 0/87863 control chromosomes. This variant was found in multiple patients with XLP (Marsh_SH2S1A_BioBlood&MarrowTranspl_2014, Chen_ItJouPed_2016, Palendira_JEM_2012). Multiple clinical diagnostic laboratories/reputable databases (including OMIM) classified this variant as pathogenic. Taken together, this variant is classified as pathogenic. - |
not provided Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Nov 01, 2019 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_addAF
Pathogenic
D
BayesDel_noAF
Pathogenic
CADD
Pathogenic
DANN
Uncertain
FATHMM_MKL
Benign
D
MutationTaster
Benign
A;A
Vest4
GERP RS
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
DS_AL_spliceai
Position offset: -25
Find out detailed SpliceAI scores and Pangolin per-transcript scores at